A Phase 2b Randomised, Double-Blind, Parallel-Group Study Of Alginate Oligosaccharide (Oligog) Dry Powder Inhalation In Addition To Standard Of Care Compared To Placebo In Addition To Standard Of Care In Patients With Cystic Fibrosis (CF)

Project: Research

Project Description

NMA HREC Reference Number: HREC/MML/51202 (V4)
NMA SSA Reference Number: SSA/51202/MonH-2019-170114(v3)
Monash Health Ref: RES-19-0000-254X
StatusActive
Effective start/end date26/04/19 → 25/04/24
View all
View less

Keywords

  • clinical trial
  • phase 2 study
  • cystic fibrosis
  • treatment efficacy
  • clinical trial
  • phase 2 study
  • cystic fibrosis
  • treatment efficacy
  • clinical trial
  • phase 2 study
  • cystic fibrosis
  • treatment efficacy